Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
N/AEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.42.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.348EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.459EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.415.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.243.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.98EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.566EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.480EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.579EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.11 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.435EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.445EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.124EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.384EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAQEWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.569EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.524EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.596.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.473EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.76.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.109EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.361EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.417EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.319EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.182EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.430EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.331EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-2308.74South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used